Pfizer, BioNTech Seek Emergency Use Authorization For COVID-19 Vaccine

Pfizer, BioNTech Seek Emergency Use Authorization For COVID-19 Vaccine

Assessment

Interactive Video

Health Sciences, Biology

University

Hard

Created by

Quizizz Content

FREE Resource

Pfizer is seeking emergency use authorization for its COVID-19 vaccine, which is reported to be 95% effective. Moderna's vaccine shows similar efficacy. The US has a contract to purchase millions of Pfizer doses, and once approved, the vaccine will be distributed free of charge.

Read more

5 questions

Show all answers

1.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What percentage effectiveness does the first COVID-19 vaccine claim to have?

90%

85%

95%

99%

2.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

Which company is associated with the first vaccine mentioned in the transcript?

AstraZeneca

Pfizer

Moderna

Johnson & Johnson

3.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

Which company developed a second vaccine showing similar results to the first?

Johnson & Johnson

Moderna

AstraZeneca

Novavax

4.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

What is the US planning to do with the Pfizer-BioNTech vaccine doses?

Sell them to other countries

Use them for research

Distribute them for free

Store them for future use

5.

MULTIPLE CHOICE QUESTION

30 sec • 1 pt

Once approved, how will the vaccine shots be provided to the public?

At a discounted price

Free of charge

Only to healthcare workers

Through private clinics only